Explore life science companies operating throughout South East England, including biotechnology firms, CROs and research organisations.
Ultrasound-based platform to enhance drug delivery into solid tumours
OxSonics is a clinical-stage biotechnology company developing a proprietary drug delivery platform that uses focused ultrasound and injectable cavitation particles to enhance the penetration of anti-cancer agents into solid tumours. The system requires no drug reformulation and includes real-time acoustic mapping to…
Manufacturer of biological reagents, sera, and QC products
TCS Biosciences is a UK manufacturer and distributor of biological reagents, quality control products, and diagnostic test kits, serving the clinical, pharmaceutical, and environmental sectors. The company is Europe's leading supplier of animal blood and sera for microbiological applications, and also supplies cell…
Mitochondrial transplantation platform to restore cellular energy and regeneration
Recondria Therapeutics is a developer of a mitochondrial transplantation platform designed to restore cellular energy, accelerate tissue recovery and support regenerative medicine. The company's approach involves isolating healthy mitochondria and delivering them to damaged cells to restore ATP production and cellular…
Cannabinoid medicines, neuroscience and oncology drug development
Jazz Pharmaceuticals is a global biopharmaceutical company focused on medicines for neuroscience and oncology. Its UK operations, centred at Kent Science Park in Sittingbourne, form the heart of its global cannabinoid manufacturing and research activities, inherited through its 2021 acquisition of GW Pharmaceuticals…
TCR therapeutic discovery platform targeting solid tumours
T-Cypher Bio is a pre-clinical biotechnology company developing T-cell receptor therapeutics using its proprietary platform, which integrates immunopeptidomics, bead-display microfluidics, and immune synapse mapping to identify novel intracellular targets and potent TCRs directly from patient tissue. The approach…
Pharmaceutical company in cardiometabolic, oncology, and immunology
Eli Lilly and Company is a multinational pharmaceutical company with UK operations headquartered in Basingstoke and an R&D site in Bracknell. Founded in 1876, Lilly's UK affiliate has operated since 1934 and employs approximately 700 people across regulatory, medical affairs, and research functions. The company…
Generative AI platform for T cell receptor and antibody therapeutics
Etcembly is a biotech company using generative AI to discover and engineer T cell receptor and antibody therapeutics. The company's platform applies large language models to TCR sequence data to design candidates with high affinity and selectivity for cancer and autoimmune disease targets. Its lead programme, ETC-101,…
Bioprocess cost and sustainability modelling software for biopharmaceutical manufacturing
Biopharm Services is a software and consulting company that helps biopharmaceutical manufacturers design and evaluate production processes before they are built. Its modelling platform lets users assemble processes from preconfigured libraries, run what-if scenarios and estimate cost of goods, facility requirements…
Carbon capture and biomanufacturing using engineered cyanobacteria
CyanoCapture is a company developing a biomanufacturing platform that uses genetically engineered cyanobacteria to sequester carbon dioxide and convert it into high-value products including recombinant proteins and graphite. Its photobioreactor-based system is designed to offer affordable carbon capture for industrial…
Biopharmaceutics and dissolution consultancy for drug product development
Biowaived is a contract research organisation providing biopharmaceutics and dissolution expertise to pharmaceutical and biotechnology companies. The company offers consultancy and laboratory-based experimental services spanning dissolution method development, physicochemical characterisation of active pharmaceutical…
AI-driven natural product discovery for neurological therapeutics
Pangea Bio is a clinical-stage biotechnology company developing small molecule therapeutics for neurological and neuropsychiatric disorders. Its proprietary AI platform screens natural and plant-derived chemical space, integrating ethnobotanical data with machine learning to identify novel CNS drug candidates with…
High-affinity sheep monoclonal antibodies for clinical diagnostic testing
Bioventix is a UK biotechnology company that creates, manufactures and supplies high-affinity sheep monoclonal antibodies for clinical diagnostic applications, particularly where conventional antibodies have failed to detect low-concentration or difficult targets. Its antibodies are supplied to major multinational in…
Multiplex PCR and NGS diagnostics for cancer and infection
GeneFirst is a molecular diagnostics company developing multiplex PCR assays and next-generation sequencing technologies for cancer screening, precision oncology and infectious disease testing. Its Papilloplex assays detect high-risk human papillomavirus DNA or E6/E7 mRNA. The XCeloSeq platform provides library…
University of Oxford GMP facility for clinical-grade biologics
The Clinical BioManufacturing Facility is the University of Oxford's GMP-licensed manufacturing facility, producing biological investigational medicinal products for early-phase clinical trials. The facility holds an MHRA Manufacturer's Authorisation for Investigational Medicinal Products and manufactures viral vector…
Generic, branded and biosimilar medicines across global therapeutic areas
Viatris UK Healthcare is the UK subsidiary of Viatris Inc., a global pharmaceutical company formed in 2020 through the combination of Mylan and Pfizer's Upjohn division. Operating from sites in Hertfordshire, Cambridge, and Sandwich, Kent, the UK entity carries out formulation and device research and development,…
Protein superglue vaccine platform targeting infectious disease and cancer
SpyBiotech is a clinical-stage biotechnology company developing vaccines using its proprietary protein superglue technology, which enables efficient and stable attachment of antigens to virus-like particle and viral vector delivery platforms. The approach improves immunogenicity and reduces manufacturing complexity…
Organ-on-chip devices and preclinical drug testing services
DLOC Biosystems is a biotechnology company developing patented organ-on-chip and human-on-chip technology for preclinical drug testing. Its microfluidic chips enable cells to grow into three-dimensional tissues that preserve in vivo properties, supporting more accurate drug safety and efficacy testing than…
Life science reagents and assay technologies distributor
2BScientific is a UK-based distributor of life science reagents, assay kits and research technologies serving academic, clinical and commercial laboratories across the UK and Europe. The company supplies a broad portfolio of molecular biology, immunology and cell biology products from global manufacturing partners,…
Transcription factor-targeting drug discovery for neurodegeneration
Scripta Therapeutics is an Oxford-based biotech company developing disease-modifying therapeutics by mapping and modulating transcription factor networks. Its platform integrates AI, imaging, and patient-derived models in a lab-in-the-loop workflow to identify compounds that restore healthy cellular states. The…
VHH single-domain antibody therapeutics for companion animals and livestock
272Bio is a biotechnology company developing biotherapeutic treatments for animal health applications across livestock and companion animals. The company applies novel antibody engineering technologies, including VHH-based biologics, to create targeted and cost-effective therapies for veterinary diseases. 272Bio…